EP2233573B1
(en)
*
|
2007-11-29 |
2013-10-23 |
Suzhou Ribo Life Science Co., Ltd |
A complex molecule interfering the expression of target genes and its preparing methods
|
US8034396B2
(en)
|
2008-04-01 |
2011-10-11 |
Tyco Healthcare Group Lp |
Bioadhesive composition formed using click chemistry
|
US8512728B2
(en)
|
2009-02-21 |
2013-08-20 |
Sofradim Production |
Method of forming a medical device on biological tissue
|
US8877170B2
(en)
|
2009-02-21 |
2014-11-04 |
Sofradim Production |
Medical device with inflammatory response-reducing coating
|
CA2753165A1
(en)
|
2009-02-21 |
2010-08-26 |
Sofradim Production |
Compounds and medical devices activated with solvophobic linkers
|
WO2010096649A1
(en)
|
2009-02-21 |
2010-08-26 |
Tyco Healthcare Group Lp |
Medical devices having activated surfaces
|
US8535477B2
(en)
|
2009-02-21 |
2013-09-17 |
Sofradim Production |
Medical devices incorporating functional adhesives
|
US9039979B2
(en)
|
2009-02-21 |
2015-05-26 |
Sofradim Production |
Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
|
EP2398845B1
(en)
|
2009-02-21 |
2017-12-13 |
Sofradim Production |
Amphiphilic compounds and self-assembling compositions made therefrom
|
US8968818B2
(en)
|
2009-02-21 |
2015-03-03 |
Covidien Lp |
Medical devices having activated surfaces
|
WO2010095055A1
(en)
|
2009-02-21 |
2010-08-26 |
Sofradim Production |
Crosslinked fibers and method of making same using uv radiation
|
US8663689B2
(en)
|
2009-02-21 |
2014-03-04 |
Sofradim Production |
Functionalized adhesive medical gel
|
US8968733B2
(en)
|
2009-02-21 |
2015-03-03 |
Sofradim Production |
Functionalized surgical adhesives
|
AU2010215203B2
(en)
|
2009-02-21 |
2015-07-16 |
Covidien Lp |
Medical devices with an activated coating
|
US8648144B2
(en)
|
2009-02-21 |
2014-02-11 |
Sofradim Production |
Crosslinked fibers and method of making same by extrusion
|
EP2398584A2
(en)
|
2009-02-21 |
2011-12-28 |
Sofradim Production |
Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices
|
GB0921665D0
(en)
|
2009-12-10 |
2010-01-27 |
Trillion Genomics Ltd |
Phobes
|
GB201001088D0
(en)
|
2010-01-23 |
2010-03-10 |
Trillion Genomics Ltd |
Detection
|
US9272074B2
(en)
|
2010-03-25 |
2016-03-01 |
Sofradim Production |
Surgical fasteners and methods for sealing wounds
|
AU2011231245B2
(en)
|
2010-03-25 |
2015-03-26 |
Covidien Lp |
Medical devices incorporating functional adhesives
|
WO2012006147A1
(en)
|
2010-06-29 |
2012-01-12 |
Tyco Healthcare Group Lp |
Microwave-powered reactor and method for in situ forming implants
|
US8865857B2
(en)
|
2010-07-01 |
2014-10-21 |
Sofradim Production |
Medical device with predefined activated cellular integration
|
CA2805987C
(en)
|
2010-07-27 |
2019-04-09 |
Sofradim Production |
Polymeric fibers having tissue reactive members
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
US8846883B2
(en)
|
2011-08-16 |
2014-09-30 |
University Of Southhampton |
Oligonucleotide ligation
|
US10344047B2
(en)
|
2012-03-01 |
2019-07-09 |
Atdbio Ltd. |
Oligonucleotide ligation
|
JP6153116B2
(en)
*
|
2013-01-09 |
2017-06-28 |
国立大学法人東北大学 |
Triazole-linked cyclic dinucleotide analogs
|
EP3578652B1
(en)
|
2013-03-15 |
2023-07-12 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
EP2971165A4
(en)
|
2013-03-15 |
2016-11-23 |
Moderna Therapeutics Inc |
ELIMINATING DNA FRAGMENTS IN METHODS OF PRODUCING MRNA
|
EP2971033B8
(en)
|
2013-03-15 |
2019-07-10 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
US9775928B2
(en)
|
2013-06-18 |
2017-10-03 |
Covidien Lp |
Adhesive barbed filament
|
WO2015006747A2
(en)
|
2013-07-11 |
2015-01-15 |
Moderna Therapeutics, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use.
|
WO2015051169A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
EP2940150A1
(en)
*
|
2014-04-29 |
2015-11-04 |
Baseclick GmbH |
Self-assembly of DNA Origami: a new diganostic tool
|
EP3157573A4
(en)
|
2014-06-19 |
2018-02-21 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2016011222A2
(en)
*
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
ES2908449T3
(en)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Polynucleotides that contain a stabilizing tail region
|
US20190194655A1
(en)
*
|
2015-12-08 |
2019-06-27 |
Solstice Biologics, Ltd. |
Polynucleotide constructs having an auxiliary moiety non-bioreversibly linked to an internucleoside phosphate or phosphorothioate
|
JP2019532027A
(en)
|
2016-08-17 |
2019-11-07 |
ソルスティス バイオロジクス,リミティッド |
Polynucleotide construct
|
EP3645546A4
(en)
|
2017-06-30 |
2021-12-01 |
Solstice Biologics, Ltd. |
CHIRAL PHOSPHORAMIDITE AIDS AND METHOD FOR THEIR USE
|
GB201714409D0
(en)
*
|
2017-09-07 |
2017-10-25 |
Univ Oxford Innovation Ltd |
Oligonucleotides and analogues thereof
|
WO2019063803A1
(en)
*
|
2017-09-29 |
2019-04-04 |
Baseclick Gmbh |
Click based ligation
|
EP3950699A4
(en)
*
|
2019-04-05 |
2023-01-18 |
Kyoto University |
Rna capping method, production method for modified rna, and modified rna
|
JP2023523345A
(en)
|
2020-04-27 |
2023-06-02 |
シックスフォールド バイオサイエンス リミテッド |
Compositions Containing Nucleic Acid Nanoparticles with Modular Functional Groups
|